Clinical Trials for Oligometastatic Disease

Find clinical trials for oligometastatic disease. Discover research opportunities and treatment options in your area.

34 Active Trials Found

Showing 34 trials on this page

Page 1 of 2

Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

NCT ID: NCT06122480

This clinical trial, called PHOLIPANC, is investigating the potential benefits of surgically removing pancreatic cancer that has spread to either the liver or lungs in patients who have already rec...

Recruiting

Phase: NA Type: interventional Locations: Baltimore, Maryland, United States

Ablative Radiosurgery vs Stereotactic RT in 5 Fractions With SIB for Oligometastatic Bone Lesions

NCT ID: NCT05679427

This clinical trial is looking at two different types of radiation therapy to treat bone metastases in patients with oligometastatic cancer, which means they have a limited number of cancer spread ...

Recruiting

Phase: NA Type: interventional Locations: Milan, Mi, Italy

Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography

NCT ID: NCT06373497

This clinical trial, called ATHERO-RT, is looking at how radiation therapy for cancer affects the heart and blood vessels in patients who are receiving treatment for specific types of cancer, parti...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Los Angeles, California, United States

Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)

NCT ID: NCT06668454

The TORO Protocol clinical trial is studying a new treatment approach for patients with oligometastatic esophagogastric cancer, which is a type of cancer that has spread to a limited number of area...

Recruiting

Phase: NA Type: interventional Locations: Toronto, Ontario, Canada

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

NCT ID: NCT05784428

This clinical trial is looking at two different ways to deliver Stereotactic Ablative Radiotherapy (SABR), a type of radiation treatment that targets small tumors with high doses of radiation. The ...

Recruiting

Phase: NA Type: interventional Locations: Vancouver, British Columbia, Canada, Prince George, British Columbia, Canada +3 more

High-Risk Metachronous Oligometastatic Prostate Cancer Trial

NCT ID: NCT06212583

This clinical trial is examining the best treatment options for men with recurrent metastatic prostate cancer that has spread to other parts of the body. The study is comparing the standard treatme...

Recruiting

Phase: PHASE2 Type: interventional Locations: Baltimore, Maryland, United States

Prospective Observational Basket Study of Stereotactic Body Radiation Therapy for OligoMetastatic Patients From Rare Tumors

NCT ID: NCT05903261

This clinical trial is studying a type of radiation therapy called Stereotactic Body Radiation Therapy (SBRT) to see how well it works and how safe it is for patients with oligometastatic disease c...

Recruiting

Type: observational Locations: Rozzano, Milan, Italy

Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers

NCT ID: NCT06918951

The STOP-2 trial is a research study comparing two types of radiation therapy for patients with a specific kind of cancer called oligoprogressive metastatic disease, which means that there are a fe...

Not yet recruiting

Phase: NA Type: interventional Locations: Surrey, British Columbia, Canada

OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)

NCT ID: NCT06462963

The OligoCare TwiCs trial, also known as the SPRINT trial, is studying the effectiveness and safety of a treatment called single-fraction stereotactic body radiation therapy (SBRT) for patients wit...

Not yet recruiting

Phase: NA Type: interventional

Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression

NCT ID: NCT06180356

The ANALLISA study is a clinical trial exploring a treatment called niraparib for women with ovarian cancer who have a specific type of disease progression called oligometastatic progression. This ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Madrid, , Spain, Barcelona, , Spain +7 more

Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing

NCT ID: NCT06842030

This clinical trial is looking at how effective two specific tests, OncoTarget and OncoTreat, can be in helping patients with oligometastatic disease, which means they have a limited number of canc...

Not yet recruiting

Phase: NA Type: interventional Locations: West Islip, New York, United States

Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

NCT ID: NCT04973007

This clinical trial is looking at two different contrast agents used during MRI scans of the liver to see which one is better at detecting liver metastases, or cancer that has spread to the liver, ...

Recruiting

Phase: PHASE4 Type: interventional Locations: Aurora, Colorado, United States

Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs

NCT ID: NCT06652022

This clinical trial is exploring the effectiveness of combining radiotherapy (a type of treatment using radiation) with systemic therapy (medication that works throughout the body) for patients wit...

Recruiting

Phase: NA Type: interventional Locations: Beijing, , China, Beijing, , China

TERPS Trial for De Novo Oligometastic Prostate Cancer

NCT ID: NCT05223803

The TERPS Trial is a research study aimed at improving the outcomes for men diagnosed with oligometastatic prostate cancer, which means they have a few cancer spots that have spread to other parts ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Pittsburgh, Pennsylvania, United States, La Jolla, California, United States +7 more

Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care

NCT ID: NCT06556550

This clinical trial is investigating a treatment called stereotactic radiation therapy for patients with oligometastatic disease, which means they have a limited number of cancer spread (metastases...

Recruiting

Phase: PHASE2 Type: interventional Locations: Obninsk, Kaluga, Russian Federation

Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer

NCT ID: NCT06439888

This clinical trial is investigating a new treatment approach for patients with oligometastatic solid tumors, which means they have a few cancer spots in different areas of the body, but not widesp...

Recruiting

Phase: PHASE1 Type: interventional Locations: Lyon, , France, Villejuif, , France

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

NCT ID: NCT05352178

This clinical trial is studying a new treatment approach for men with a specific type of prostate cancer called oligorecurrent hormone-sensitive prostate cancer. The researchers want to see if addi...

Recruiting

Phase: PHASE3 Type: interventional Locations: Leuven, , Belgium

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

NCT ID: NCT06430411

The OLIGOMET study is looking into the best ways to treat patients with oligometastatic prostate cancer, which means their cancer has spread just a little bit, often to a few spots in the bones or ...

Not yet recruiting

Type: observational

Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor

NCT ID: NCT06190782

This clinical trial is studying a treatment approach for patients with a specific type of esophageal cancer called oligometastatic esophageal squamous cell carcinoma. This means the cancer has spre...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, , China

Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma

NCT ID: NCT05128201

This clinical trial is investigating a new treatment approach for patients with oligometastatic nasopharyngeal carcinoma, which means they have a limited number of cancer spread areas (five or fewe...

Recruiting

Phase: PHASE2 Type: interventional Locations: Nanchang, Jiangxi, China, Fuzhou, Fujian, China +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions